“All providers in the healthcare system should practice to the fullest extent allowed by their license.”
From July 29 to Aug. 18, people have donated $15.6 million to the ALS Association as the result of the viral Ice Bucket Challenge.
Mallinckrodt announced that it has completed the acquisiton of Questcor Pharmaceuticals in a transaction valued at $5.8 billion.
The Food and Drug Administration announced approval of a new use for Avastin (bevacizumab), to treat patients with persistent, recurrent or late-stage cervical cancer.
Beginning in August, Wegmans Food Markets is now offering an enhanced Specialty Pharmacy Service for medications used to treat conditions in the fields of rheumatology, gastroenterology, neurology and dermatology.
The National Association of Specialty Pharmacy on Thursday announced that Bob Fulcher has joined the organization as COO.
Diplomat on Thursday announced that its president, Gary Kadlec, has been elected to the board of directors for the American Foundation of Pharmaceutical Education.
The Food and Drug Administration approved Lumizyme (alglucosidase alfa) for treatment of patients with infantile-onset Pompe disease, including patients who are younger than 8 years of age.
McKesson on Thursday reported revenues of $44.1 billion for the first quarter ended June 30, up 37%.
The Food and Drug Administration on Monday expanded the approved use of Imbruvica (ibrutinib) to treat patients with chronic lymphocytic leukemia who carry a deletion in chromosome 17.